GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Labcorp Holdings Inc (FRA:N6B) » Definitions » Debt-to-Revenue

Labcorp Holdings (FRA:N6B) Debt-to-Revenue : 0.47 (As of Mar. 2024)


View and export this data going back to 1991. Start your Free Trial

What is Labcorp Holdings Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Labcorp Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €2,042 Mil. Labcorp Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €3,449 Mil. Labcorp Holdings's annualized Revenue for the quarter that ended in Mar. 2024 was €11,690 Mil. Labcorp Holdings's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 was 0.47.


Labcorp Holdings Debt-to-Revenue Historical Data

The historical data trend for Labcorp Holdings's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labcorp Holdings Debt-to-Revenue Chart

Labcorp Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.62 0.48 0.48 0.53 0.49

Labcorp Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.52 0.51 0.52 0.49 0.47

Competitive Comparison of Labcorp Holdings's Debt-to-Revenue

For the Diagnostics & Research subindustry, Labcorp Holdings's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Labcorp Holdings's Debt-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Labcorp Holdings's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Labcorp Holdings's Debt-to-Revenue falls into.



Labcorp Holdings Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Labcorp Holdings's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(1074.724 + 4385.277) / 11152.187
=0.49

Labcorp Holdings's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(2041.664 + 3449.356) / 11689.888
=0.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2024) Revenue data.


Labcorp Holdings Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Labcorp Holdings's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Labcorp Holdings (FRA:N6B) Business Description

Traded in Other Exchanges
Address
358 South Main Street, Burlington, NC, USA, 27215
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.

Labcorp Holdings (FRA:N6B) Headlines

No Headlines